Blog
Wall Street Analysts Think Phathom Pharmaceuticals (PHAT) Could Surge 87.21%: Read This Before Placing a Bet
Phathom Pharmaceuticals, Inc. (PHAT) closed the last trading session at $10.95, gaining 21% over the past four weeks, but there could be plenty of upside left in the stock if short-term price
Wall Street Analysts See a 142.26% Upside in Pharming Group (PHAR): Can the Stock Really Move This High?
Pharming Group N.V. Sponsored ADR (PHAR) closed the last trading session at $12.66, gaining 24.2% over the past four weeks, but there could be plenty of upside left in the stock if short-term price
After Golden Cross, Alector (ALEC)'s Technical Outlook is Bright
After reaching an important support level, Alector, Inc. (ALEC) could be a good stock pick from a technical perspective. ALEC recently experienced a "golden cross" event, which saw its 50-day simple
Helios Technologies (HLIO) Just Flashed Golden Cross Signal: Do You Buy?
Helios Technologies, Inc (HLIO) is looking like an interesting pick from a technical perspective, as the company reached a key level of support. Recently, HLIO's 50-day simple moving average crossed
Wall Street Analysts Think Mersana Therapeutics (MRSN) Could Surge 248.83%: Read This Before Placing a Bet
Mersana Therapeutics, Inc. (MRSN) closed the last trading session at $8.11, gaining 0.7% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets
Wall Street Analysts Think Shoals Technologies (SHLS) Could Surge 25.87%: Read This Before Placing a Bet
Shares of Shoals Technologies Group (SHLS) have gained 2.7% over the past four weeks to close the last trading session at $5.76, but there could still be a solid upside left in the stock if
GILD Stock Slips as CVS Health Excludes New HIV Drug Yeztugo
Shares of Gilead Sciences, Inc. (GILD) tumbled 2.2% on Aug. 21, after pharmacy benefit manager CVS Health (CVS) decided not to add the former’s new HIV prevention drug, Yeztugo (lenacapavir), to its
Should Boston Scientific Stock Be in Your Portfolio Right Now?
Boston Scientific’s BSX second-quarter 2025 performance was driven by its robust expansion of operations across different geographies outside the United States. The company’s impressive growth
Shell Teams Up to Boost FPSO Safety Using AI and Data Analysis
Shell plc SHEL has teamed up with Japanese Floating Production Storage and Offloading (“FPSO”) specialist Modec, Brazil’s State University of Campinas (Unicamp) and digital solutions company Shape
Strong Cash Flow Keeps ExxonMobil Ahead in a Volatile Energy Market
Exxon Mobil Corporation XOM continues to demonstrate robust financial strength built on consistent free cash flow generation across its integrated operations, including upstream, downstream and
PPL vs. FirstEnergy: Which Utility Stock Powers Up Stronger Returns?
Utility service providers benefit from a number of positive factors, including increased electricity tariffs, accretive acquisitions, cost reductions and the deployment of energy-efficiency
Stryker's Robotics and Global Gains Offset by Macro Concerns
Stryker Corporation SYK posted robust second-quarter 2025 results, with broad-based momentum across its core businesses. Net sales grew 11.1% year over year to $6.1 billion, while organic sales
NVIDIA's Data Center Grows Fast: Can It Sustain the Momentum?
NVIDIA Corporation’s NVDA Data Center business has become its primary growth engine, driven by increasing demand for artificial intelligence (AI) infrastructure. In the first quarter of fiscal 2026
NVIDIA Likely to Beat Q2 Earnings Estimate: How to Play the Stock?
NVIDIA Corporation NVDA is likely to beat on earnings when it reports second-quarter fiscal 2026 results on Aug. 27, after market close.
The company expects revenues of $45 billion (+/-2%) for the
Why This 1 Momentum Stock Could Be a Great Addition to Your Portfolio
It doesn't matter your age or experience: taking full advantage of the stock market and investing with confidence are common goals for all investors. Luckily, Zacks Premium offers several different
Here's Why Veracyte (VCYT) is a Strong Momentum Stock
It doesn't matter your age or experience: taking full advantage of the stock market and investing with confidence are common goals for all investors. Luckily, Zacks Premium offers several different
Here's Why Idexx Laboratories (IDXX) is a Strong Momentum Stock
Taking full advantage of the stock market and investing with confidence are common goals for new and old investors, and Zacks Premium offers many different ways to do both.
The research service
Here's Why TransMedics (TMDX) is a Strong Momentum Stock
For new and old investors, taking full advantage of the stock market and investing with confidence are common goals. Zacks Premium provides lots of different ways to do both.
Featuring daily updates
Are You a Momentum Investor? This 1 Stock Could Be the Perfect Pick
It doesn't matter your age or experience: taking full advantage of the stock market and investing with confidence are common goals for all investors. Luckily, Zacks Premium offers several different
Why Palantir Technologies Inc. (PLTR) is a Top Momentum Stock for the Long-Term
It doesn't matter your age or experience: taking full advantage of the stock market and investing with confidence are common goals for all investors. Luckily, Zacks Premium offers several different
Why National Fuel Gas (NFG) is a Top Momentum Stock for the Long-Term
For new and old investors, taking full advantage of the stock market and investing with confidence are common goals. Zacks Premium provides lots of different ways to do both.
Featuring daily updates
Are You a Momentum Investor? This 1 Stock Could Be the Perfect Pick
It doesn't matter your age or experience: taking full advantage of the stock market and investing with confidence are common goals for all investors. Luckily, Zacks Premium offers several different
Here's Why American International Group (AIG) is a Strong Momentum Stock
Taking full advantage of the stock market and investing with confidence are common goals for new and old investors, and Zacks Premium offers many different ways to do both.
The research service
Affirm Holdings (AFRM) is a Top-Ranked Momentum Stock: Should You Buy?
It doesn't matter your age or experience: taking full advantage of the stock market and investing with confidence are common goals for all investors. Luckily, Zacks Premium offers several different



